Results 81 to 90 of about 67,859 (248)
Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022
A nationwide survey of SARS-CoV-2 antinucleocapsid seroprevalence among blood donors in Japan revealed that, as of November 2022, infection-induced seroprevalence of the population was 28.6% (95% CI 27.6%–29.6%).
Ryo Kinoshita+7 more
doaj +1 more source
Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust
Healthcare workers (HCWs) have a theoretically increased risk of contracting severe acute respiratory coronavirus virus 2 (SARS-CoV-2) given their occupational exposure.
Joseph J. Grant+9 more
semanticscholar +1 more source
ABSTRACT Epstein–Barr virus (EBV)‐positive smooth muscle tumors (SMTs) are rare tumors seen in immunocompromised patients. There is no clear standard of care for the management and treatment of EBV‐SMTs. Patients are often treated with chemotherapy, surgery, and/or radiation.
Meghan Haney+7 more
wiley +1 more source
Seroprevalence of hepatitis A in children and adolescents [PDF]
To determine the seroprevalence of hepatitis A (HAV) in children and adolescents aged 1 to 14 years, and to identify factors associated with a history of infection.This was a cross-sectional epidemiological study, conducted form February to August 2006 in the city of Curitiba, Paraná, Brazil, and the surrounding municipalities (Greater Curitiba ...
Cristina R. Cruz+4 more
openaire +2 more sources
BACKGROUND Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused over one million deaths worldwide, thus there is an urgent need to develop preventive and therapeutic strategies.
M. N. Rivas+8 more
semanticscholar +1 more source
Objectives We aimed to estimate the seroprevalence of COVID-19 in a rural district of South India, six months after the index case. Methodology We conducted a cross-sectional study of 509 adults aged more than 18 years.
L. Inbaraj, C. George, S. Chandrasingh
semanticscholar +1 more source
The study explored the clinical characteristics and risk factors of HBoV‐positive severe pneumonia in children. These findings indicate that HBoV can be identified in respiratory samples from children with severe pneumonia, denoting its role as a viral pathogen in hospitalized children with this condition.
Jing Liao+6 more
wiley +1 more source
Transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is ongoing in many communities throughout the United States. Although case-based and syndromic surveillance are critical for monitoring the pandemic, these systems ...
H. Biggs+40 more
semanticscholar +1 more source
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance.
I. Adetifa+34 more
semanticscholar +1 more source
Advancing dengue vaccine development: Challenges, innovations, and the path toward global protection
Dengue vaccine development faces challenges, including antibody‐dependent enhancement and serotype‐specific immunity. This review highlights licensed vaccines, CYD‐TDV, TAK‐003, and Butantan‐DV, and explores strategies for achieving effective multivalent protection.
Ran Wang+3 more
wiley +1 more source